Capricor Therapeutics Company Insiders

Capricor Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.3473) % which means that it has lost $0.3473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8907) %, meaning that it created substantial loss on money invested by shareholders. Capricor Therapeutics' management efficiency ratios could be used to measure how well Capricor Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/24/2025, Return On Tangible Assets is likely to drop to -0.36. In addition to that, Return On Capital Employed is likely to grow to -0.96. At this time, Capricor Therapeutics' Total Assets are relatively stable compared to the past year. As of 03/24/2025, Total Current Assets is likely to grow to about 89.3 M, though Non Currrent Assets Other are likely to grow to (80.8 M). As of 03/24/2025, Common Stock Shares Outstanding is likely to grow to about 37 M, though Net Loss is likely to grow to (24.8 M).

Capricor Therapeutics Workforce Comparison

The company has Profit Margin (PM) of (1.82) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.69) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.69.

Capricor Therapeutics Insider Trading History

Capricor Therapeutics Notable Stakeholders

The success or failure of an entity such as Capricor Therapeutics often depends on how effective the management is. Capricor Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Capricor management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Capricor management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.